Arzneiverordnungs-Report 2025

Arzneiverordnungs-Report 2025 has now been released

 

Arzneiverordnungs-Report 2025 | Springer Nature Link


Latest Publications

Ecker PAM Seifert RSchaper A, Bräuning HJ, Seifert R

 Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin. Eur J Clin Pharmacol. 2026 Jun 23;82(7):186. doi: 10.1007/s00228-026-04099-3. PMID: 42334625; PMCID: PMC13290837.

Ried PFGSeifert R

Drug-induced gingival overgrowth: evaluation of an online survey. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 20. doi: 10.1007/s00210-026-05600-6. Epub ahead of print. PMID: 42321579

Joshua Kinzel,Seifert R

A Survey of German Dentists on the Prophylactic Use of Antibacterial Drugs in Patients in Risk Groups: Diabetes, Joint Replacement, Risk of Endocarditis, and Immunosuppression or Organ Transplantation. Int J Dent. 2026 Jun 19;2026:8452465. doi: 10.1155/ijod/8452465. PMID: 42325694; PMCID: PMC13280459. 

Bindel LJ, Seifert R

Pharmacological assessment of drugs retained in the 1st and 24th WHO Essential Medicines List (1977-2025). Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 17. doi: 10.1007/s00210-026-05555-8. Epub ahead of print. PMID: 42307638.

Rotter JMSeifert R

Drug supply shortages and their consequences for the medical profession: a survey in Germany and Austria. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 6. doi: 10.1007/s00210-026-05484-6. Epub ahead of print.

Donner K,  Seifert R

Selenium containing dietary supplements: Market-, efficacy- and risk analysis. J Trace Elem Med Biol. 2026 Jun;95:127903. doi: 10.1016/j.jtemb.2026.127903. Epub 2026 Jun 1. PMID: 42241865.

Schmoll ESeifert R

Pharmacological content in the television series "House MD": analysis from a German pharmacologist's perspective. Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):10615-10641. doi: 10.1007/s00210-026-04995-6. Epub 2026 Feb 7. PMID: 41652009;

Ried PFGSeifert R

Social media data and its potential for pharmacovigilance: a comparative analysis of reported prevalences regarding drug-induced gingival overgrowth (DIGO). Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):9673-9694. doi: 10.1007/s00210-026-04983-w. Epub 2026 Jan 23. 

Krug E, Seifert R

Analysis of the use of trade names versus active ingredient names using the example of acetylsalicylic acid and Aspirin® in the Frankfurter Allgemeine Zeitung. Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):9585-9606. doi: 10.1007/s00210-025-04788-3. Epub 2026 Jan 22. PMID: 41565878; PMCID: PMC13152897.

Hitsch F, Seifert R

Correction to: Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006-2024. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 8. doi: 10.1007/s00210-026-05562-9. Epub ahead of print. Erratum for: Naunyn Schmiedebergs Arch Pharmacol. 2026 May 22. doi: 10.1007/s00210-026-05443-1. PMID: 42252342.

Rotter JM, Seifert R

Drug supply shortages and their perceived consequences for patients: a questionnaire survey of German and Austrian physicians, Eur J Clin Pharmacol, 2026 May 1;82(5):138., doi: 10.1007/s00228-026-04052-4.

Tödter AL, Seifert R.

Critical analysis of the prescription and evaluation of monoclonal antibodies approved in Germany for the outpatient setting from 2010-2021, Naunyn Schmiedebergs Arch Pharmacol 2026 Apr 7.doi: 10.1007/s00210-026-05201-3. Epub Online ahead of print.

Bindel LJ, Seifert R.

US Food and Drug Administration black box warnings: Characteristics of drug classes and adverse effects, J Pharmacol Exp Ther 2026 Apr;393(4):104317. doi: 10.1016/j.jpet.2026.104317. Epub 2026 Mar 16., 

Steinert, JM, Seifert R

A brief history of the German Society for Experimental and Clinical Pharmacology and Toxicology-an overview of available sources, Naunyn Schmiedebergs Arch Pharmacol 2026 Mar 28, doi: 10.1007/s00210-026-05197-w. Epub ahead of print. PMID: 41896404

Steinert, JM, Seifert R

Correction: The Schmiedeberg Medal of the German Society for Experimental and Clinical Pharmacology and Toxicology: a biographical and bibliometric analysis of the 47 recipients from 1956 to 2024, Naunyn Schmiedebergs Arch Pharmacol 2026 Mar 24, doi: 10.1007/s00210-026-05256-2. Epub Online ahead of print. PMID: 41872589

Bindel LJ, Seifert R.

Antidepressant drug use in Europe: past consumption, prescribing patterns and forecast until 2030, Int J Clin Pharm, 2026 Mar 10. doi: 10.1007/s11096-025-02078-9. Epub Online ahead of print., PMID: 4180613

Rotter JMSeifert R

Drug supply shortages and their consequences for the medical profession: a survey in Germany and Austria. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 6. doi: 10.1007/s00210-026-05484-6. Epub ahead of print.

Donner K,  Seifert R

Selenium containing dietary supplements: Market-, efficacy- and risk analysis. J Trace Elem Med Biol. 2026 Jun;95:127903. doi: 10.1016/j.jtemb.2026.127903. Epub 2026 Jun 1. PMID: 42241865.

Schmoll ESeifert R

Pharmacological content in the television series "House MD": analysis from a German pharmacologist's perspective. Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):10615-10641. doi: 10.1007/s00210-026-04995-6. Epub 2026 Feb 7. PMID: 41652009;

Ried PFGSeifert R

Social media data and its potential for pharmacovigilance: a comparative analysis of reported prevalences regarding drug-induced gingival overgrowth (DIGO). Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):9673-9694. doi: 10.1007/s00210-026-04983-w. Epub 2026 Jan 23. 

Krug E, Seifert R

Analysis of the use of trade names versus active ingredient names using the example of acetylsalicylic acid and Aspirin® in the Frankfurter Allgemeine Zeitung. Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):9585-9606. doi: 10.1007/s00210-025-04788-3. Epub 2026 Jan 22. PMID: 41565878; PMCID: PMC13152897.

Hitsch F, Seifert R

Correction to: Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006-2024. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 8. doi: 10.1007/s00210-026-05562-9. Epub ahead of print. Erratum for: Naunyn Schmiedebergs Arch Pharmacol. 2026 May 22. doi: 10.1007/s00210-026-05443-1. PMID: 42252342.

Rotter JM, Seifert R

Drug supply shortages and their perceived consequences for patients: a questionnaire survey of German and Austrian physicians, Eur J Clin Pharmacol, 2026 May 1;82(5):138., doi: 10.1007/s00228-026-04052-4.

Tödter AL, Seifert R.

Critical analysis of the prescription and evaluation of monoclonal antibodies approved in Germany for the outpatient setting from 2010-2021, Naunyn Schmiedebergs Arch Pharmacol 2026 Apr 7.doi: 10.1007/s00210-026-05201-3. Epub Online ahead of print.

Bindel LJ, Seifert R.

US Food and Drug Administration black box warnings: Characteristics of drug classes and adverse effects, J Pharmacol Exp Ther 2026 Apr;393(4):104317. doi: 10.1016/j.jpet.2026.104317. Epub 2026 Mar 16., 

Steinert, JM, Seifert R

A brief history of the German Society for Experimental and Clinical Pharmacology and Toxicology-an overview of available sources, Naunyn Schmiedebergs Arch Pharmacol 2026 Mar 28, doi: 10.1007/s00210-026-05197-w. Epub ahead of print. PMID: 41896404

Steinert, JM, Seifert R

Correction: The Schmiedeberg Medal of the German Society for Experimental and Clinical Pharmacology and Toxicology: a biographical and bibliometric analysis of the 47 recipients from 1956 to 2024, Naunyn Schmiedebergs Arch Pharmacol 2026 Mar 24, doi: 10.1007/s00210-026-05256-2. Epub Online ahead of print. PMID: 41872589

Bindel LJ, Seifert R.

Antidepressant drug use in Europe: past consumption, prescribing patterns and forecast until 2030, Int J Clin Pharm, 2026 Mar 10. doi: 10.1007/s11096-025-02078-9. Epub Online ahead of print., PMID: 4180613

 

Home

Back to homepage

Home
Contact

Our staff

Contact
Teaching

Link to the eLearning platform ILIAS

Teaching
Research focus

Cyclic nucleotides, histamine H4 receptor

Research
Publications

Publications of the institute (2019-2024)

Publications
Research Core Unit Metabolomics

GC and LC-MS/MS analyses

Metabolomics